Sort
85,873 grants matching “alzheimers”
Autophagon: an Autophagy-Functionalizing Gene Therapy Tool for Neurodegenerative Diseases
$749,845Abraam M. Yakoub · Brigham And Women'S Hospital · R01 · FY2025 · AG
The Influence of Structural Racism on Incidence of Alzheimer's Disease and Related Dementias (ADRD) in Black women
$749,820Lynn Rosenberg · Boston University Medical Campus · R01 · FY2023 · AG
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
$749,807Miles Berger · Duke University · R01 · FY2023 · AG
Tau Oligomer Platform Validation Using Lead Series Candidate in htau Mice
$749,795James G. Moe · Oligomerix, Inc · R44 · FY2017 · AG
Tau Oligomer Platform Validation Using Lead Series Candidate in htau Mice
$749,795James G. Moe · Oligomerix, Inc · R44 · FY2016 · AG
Hopkins Economics of Alzheimer's Disease & Services Center
$749,788Jennifer L Wolff · Johns Hopkins University · P30 · FY2025 · AG
Dementia and Related Health and Social Challenges in Lebanon: A Population Study
$749,759Carlos F. Mendes De Leon · University Of Michigan At Ann Arbor · R01 · FY2020 · AG
Epidemiologic Study of Decision Making in Preclinical Alzheimer's Disease
$749,758Patricia A Boyle · Rush University Medical Center · R01 · FY2023 · AG
Leveraging the Human Non-Coding Transcriptome to Identify Therapeutics for Healthy Aging and Alzheimers Disease
$749,747Claes Robert Wahlestedt · University Of Miami School Of Medicine · R56 · FY2018 · AG
Mapping Synaptic Density in Prodromal and Manifest Lewy Body Dementia
$749,746Catherine L. Gallagher · University Of Wisconsin-Madison · R01 · FY2025 · AG
CLINICAL STUDIES OF NSAIDSs AS y-SECRETASE MODULATORS IN ALZHEIMER'S DISEASE
$749,734Douglas R Galasko · University Of California, San Diego · P01 · FY2011 · AG
The Engaging Communities of Hispanics for Aging Research (ECHAR) Network
$749,708Luis D Medina · University Of Houston · R24 · FY2020 · AG
New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease
$749,693Franco Vitaliano · Exqor Technologies, Inc. · R44 · FY2018 · AG
CommunityRx-Dementia
$749,650Stacy Tessler Lindau · University Of Chicago · R01 · FY2022 · AG
Human iPSC Models Core
$749,642Celeste Marie Karch · Mayo Clinic Jacksonville · U19 · FY2025 · AG
COGNITIVE TRAINING AND NEUROPLASTICITY IN MILD COGNITIVE IMPAIRMENT
$749,559Davangere P Devanand · Columbia University Health Sciences · R01 · FY2018 · AG
Role of KDM6B in Alzheimerâs disease related dementia
$749,508Yingfei Wang · Ut Southwestern Medical Center · R01 · FY2023 · AG
Role of KDM6B in Alzheimerâs disease related dementia
$749,508Yingfei Wang · Ut Southwestern Medical Center · R01 · FY2024 · AG
COBRE for Perinatal Biology
$749,496Sunil K Shaw · Women And Infants Hospital-Rhode Island · P30 · FY2019 · GM
Regulation of human tau expression and tauopathy by alpha-synuclein
$749,496Michael K Lee · University Of Minnesota · R01 · FY2025 · AG
New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease
$749,493Franco Vitaliano · Exqor Technologies, Inc. · R44 · FY2019 · AG
Purpose in life: Mechanisms to support healthier cognitive aging and reduce risk of Alzheimer's disease
$749,459Angelina R Sutin · Florida State University · R01 · FY2022 · AG
A non-pharmacological intervention for patients with Alzheimer s disease and family caregivers
$749,437Sara J. Czaja · University Of Miami School Of Medicine · R01 · FY2016 · AG
Evaluating the disease-modifying potential of a sleep intervention for Alzheimer's Disease outcomes
$749,427Natalie L Denburg · University Of Iowa · R01 · FY2021 · AG
Automated brain parcellation and morphometry
$749,423Michael E Smith · Cortechs Labs, Inc. · R44 · FY2006 · AG